Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-17T19:46:08.520Z Has data issue: false hasContentIssue false
  • English
  • Français

Measuring the economic benefit of treatment with atypical antipsychotics

Published online by Cambridge University Press:  16 April 2020

MRJ Knapp
MRJ Knapp*
Affiliation:
Personal Social Services Research Unit, London School of Economics and Political Science, Houghton Street, LondonWC2A 2AE ; Centre of the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, Denmark Hill, LondonSE8, UK
Get access

Summary

Schizophrenia has a major impact on the quality of life of sufferers, and its broader impact on families and on society are well known, although less thoroughly documented. The majority of sufferers require long-term treatment and support, and there are depressingly frequent media stories about violent incidents involving people with the illness. Consequently the costs of schizophrenia, broadly defined, loom large, not just from the perspective of health care decision-makers and governments, but also from that of sufferers and their families, to many other people with only indirect experience of the disease.

Keywords

schizophreniacostssocietyatypical antipsychoticseconomic evaluation
Type
Research Article
Information
European Psychiatry , Volume 13 , Issue S1 , 1998 , pp. 37s - 45s
Copyright
Copyright © Elsevier, Pari 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alleback, PSchizophrenia: a life-shortening disease Schiz Bull 1989; 15: 81–89CrossRefGoogle Scholar
Amaddeo, F, Beecham, JK, Bonizzato, P, Fenyo, A, Knapp, MRJ, Tansella, M. The use of a case register for evaluating the costs of psychiatric care Acta Psychiatr Scand, in press.Google Scholar
Andrews, G, Hall, W, Goldstein, G, et al.The economic costs of schizophrenia: implications for public policy Arch Gen Psychiatry 1985; 42: 537–543CrossRefGoogle ScholarPubMed
Audit Commission Finding a Place Geneva: HMSO, 1994Google Scholar
Beecham, JK, Hallam, A, Knapp, M.R.J., Baines, B, Fenyo, A, Asbury, MCosting care in the hospital and in the communityLeff, JCommunity Care: Illusion or Reality? London: Wiley, 1997Google Scholar
Bloor, K, Freemantle, NLessons from international e cperience in controlling pharmaceutical expenditure II: influencing doctors Br Med J 1996; 312: 1525CrossRefGoogle Scholar
Chisholm, D, Knapp, M.R.J., Astin, J, Beecham, J, Audini, B, Lelliott, PThe costs of residential care for people with mental health problems in eight services J M Health 1997Google Scholar
Davies, LM, Drummond, MFEconomics and schizophrenia: the real cost Br J Psychiatry 165suppl 251994 18–21CrossRefGoogle Scholar
Department of Health Health and Personal Social Services Statistics for England Chichester: HMSO, 1994Google Scholar
Drummond, MFCost-of-illness studies: a major headache? Pharmacoeconomics 1992; 2: 1–4CrossRefGoogle ScholarPubMed
Drummond, MF, O'Brien, B, Stoddart, GL, Torrance, GWMethods for the Economic Evaluation of Health Care Programmes 2nd ed. London: Oxford Medical Publications, 1997Google Scholar
Evers, SMAA, Ament, AJHACosts of schizophrenia in the Netherlands Schizophr Bull 1995; 21: 141–153CrossRefGoogle ScholarPubMed
Freemantle, N, Bloor, KLessons from international experience in controlling pharmaceutical expenditure 1: influencing patients Br Med J 1996; 312: 1469–1471CrossRefGoogle Scholar
Hallam, ACosts and outcomes for people with special psychiatric needs Ment Health Res Rev 1996; 3: 10Google Scholar
Hogman, GIs Cost a Factor? Oxford: National Schizophrenia Fellowship, 1996Google Scholar
Hyde, C, Harrower-Wilson, CResource consumption in psychiatric intensive care: the cost of aggression Psychiatr Bull 1995; 19: 73–76CrossRefGoogle Scholar
Kavanagh, SM, Stewart, AEconomic evaluations of mental health care: modes and methodsKnapp, M.R.J.The Economic Evaluation of Mental Health Care London: Arena, 1995Google Scholar
Kavanagh, S, Opit, L, Knapp, M.R.J., Beecham, JSchizophrenia: shifting the balance of care Soc Psychiatr Epidemiol 1995; 30: 206–212Google ScholarPubMed
Kerwin, RWAn essay on the new antipsychotics Psychiatr Bull 1996; 20: 23–29CrossRefGoogle Scholar
Knapp, M.R.J.Costs of schizophrenia Br J Psychiatry 1997; 171: 509–518CrossRefGoogle ScholarPubMed
Knapp, M.R.J., Beecham, JK, Koutsogeorgopoulou, V, Hallam, A, Fenyo, A, Marks, I, et al.Service use and costs of home-based versus hospital-based care for people with serious mental illness Br J Psychiatry 1994; 165: 195–203CrossRefGoogle ScholarPubMed
Lehman, AF, Thompson, JW, Dixon, LB, Scott, JESchizophrenia: treatment outcomes research Schizophr Bull 1995; 21: 561–566CrossRefGoogle ScholarPubMed
Lieberman, JA, Fleischhacker, WWCurrent Issues in the Development of Atypical Antipsychotic Drugs Br J Psychiatry 168 suppl 29 1996Google Scholar
Macmillan, JF, Crow, TJ, Johnson, AL, Johnstone, ECThe Northwick Park study of first episodes of schizophrenia. III Short term outcome in trial entrants and trial-eligible patient Br J Psychiatry 1986; 148: 128–133CrossRefGoogle Scholar
National Health Service Executive Burden of disease London: NHSE, 1996Google Scholar
Netten, A, Dennett, JUnit Costs of Health and Social Care 1996 London: Personal Social Services Research Unit, University of Kent at Canterbury, 1996Google Scholar
Rice, DP, Kelman, S, Miller, LS, et al.The Economic Costs of Alcohol and Drug Abuse and Mental Illness: 1985 Rockville: National Institute of Mental Health DHSS Pub No (ADM) 90-16941990Google Scholar
Ritchie, JH, Dick, D, Lingham, RThe Report of the Inquiry into the Care and Treatment of Christopher Clunis Canterbury: HMSO, 1994Google Scholar
Schene, AH, Tessler, RC, Gamache, GMInstruments measuring family or caregiver burden in severe mental illness Soc Psychiatry Psychiatr Epidemiol 1994; 28: 11–16Google Scholar
Sheldon, TProblems of using modelling in the economic evaluation of health care Health Econ 1996; 5: 1–123.0.CO;2-K>CrossRefGoogle ScholarPubMed
Shepherd, M, Watt, D, Falloon, I, et al.The natural history of schizophrenia: a five-year follow-up study of outcome and prediction in a representative sample of schizophrenics Psych Med 1989; 15: 1–44Google Scholar
Szmukler, GFrom family burden to caregiving Psychiatr Bull 1996; 20: 449–451CrossRefGoogle Scholar
Weiden, PJ, Olfson, MCost of relapse in schizophrenia Schizophr Bull 1995; 21: 419–429CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.